Patents by Inventor Geping Cui

Geping Cui has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR TREATING ALZHEIMER'S DISEASE AND PARKINSON'S DISEASE
    Publication number: 20200323873
    Abstract: Pharmaceutical compositions comprising azelastine, or a pharmaceutically acceptable salt of azelastine, and methylcobalamin are disclosed. Methods of using the pharmaceutical compositions for treating patients with Alzheimer's disease or Parkinson's disease are also disclosed.
    Type: Application
    Filed: June 26, 2020
    Publication date: October 15, 2020
    Inventors: Jianmin Wang, Geping Cui
  • METHOD OF TREATING DEMENTIA
    Publication number: 20200323870
    Abstract: Methods of treating patients suffering from or exhibiting symptoms of mental, behavioral, and/or cognitive disorders with azelastine or a pharmaceutically acceptable salt of azelastine are disclosed.
    Type: Application
    Filed: March 26, 2020
    Publication date: October 15, 2020
    Inventors: Jianmin Wang, Geping Cui
  • Method of treating Alzheimer's disease
    Patent number: 10639314
    Abstract: Methods of treating patients suffering from or exhibiting symptoms of mental, behavioral, and/or cognitive disorders with azelastine or a pharmaceutically acceptable salt of azelastine is disclosed.
    Type: Grant
    Filed: April 30, 2019
    Date of Patent: May 5, 2020
    Assignee: LA PharmaTech Inc.
    Inventors: Jianmin Wang, Geping Cui
  • Method of treating Parkinson's disease
    Patent number: 10639316
    Abstract: Methods of treating patients suffering from or exhibiting symptoms of mental, behavioral, and/or cognitive disorders with azelastine or a pharmaceutically acceptable salt of azelastine is disclosed.
    Type: Grant
    Filed: May 30, 2019
    Date of Patent: May 5, 2020
    Assignee: LA PharmaTech Inc.
    Inventors: Jianmin Wang, Geping Cui
  • Pharmaceutical compositions and methods for treating Alzheimer's disease
    Patent number: 10639315
    Abstract: A pharmaceutical composition containing the therapeutically active ingredients of azelastine or a pharmaceutically acceptable salt of azelastine and donepezil or rivastigmine or galantamine or a pharmaceutically acceptable salt of thereof is disclosed. A method of using the pharmaceutical composition for treating patients suffering from mental, behavioral, cognitive disorders is also disclosed.
    Type: Grant
    Filed: May 21, 2019
    Date of Patent: May 5, 2020
    Assignee: LA PharmaTech Inc.
    Inventors: Jianmin Wang, Geping Cui